68083-412-10 : NDC 2026 Code

68083-412-10 : Cangrelor ( Cangrelor )

Additionally :

You can get information about “68083-412-10” NDC code in 68083-412-10 in HTML format

HTML | 68083-412-10 in TXT (Plain Text) format

TXT | 68083-412-10 in PDF (Portable Document Format)

PDF | 68083-412-10 in XML format

XML formats.

NDC Code : 68083-412-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68083-412-10",
    "PackageDescription": "10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "68083-0412-10",
    "ProductNDC": "68083-412",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cangrelor",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cangrelor",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20250811",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA213551",
    "LabelerName": "Gland Pharma Limited",
    "SubstanceName": "CANGRELOR",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-08-22",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250811",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}